Evercore ISI downgraded Albemarle (ALB) to In Line from Outperform with a price target of $88, down from $170. With “little reason to believe” a lithium price recovery lies ahead this year and the firm’s 2025 bridge math pointing toward $875M in EBITDA at $12/kg, or 17% below consensus at $1.05B, the firm is downgrading shares along with the transfer of lead coverage. EBITDA appears on pace to contract in 2025 for the third consecutive year, the analyst tells investors.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio